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Among a series of T cell subsets, Th2 cells are crucially impli-
cated in the pathogenesis of allergic diseases.1 This cell type plays
a pivotal role in inducing serum IgE response and airway eosino-
philic inﬂammation accompanied by bronchial hyperresponsive-
ness (BHR).1 Furthermore, activated Th2 cells themselves
inﬁltrate into the inﬂammatory tissues with the assistance of
several adhesion molecules.2 Recently, another T cell subset, Th17,
has been shown to participate in the development of allergic dis-
eases.3 However, the comparable information regarding the role
of adhesion molecules in Th2- and Th17-mediated allergic inﬂam-
mation has not been accumulated.
We have demonstrated the critical contribution of a glycopro-
tein, CD44 to lung migration of antigen-speciﬁc T cells by employ-
ing its neutralizing antibody (Ab).4 Furthermore, the binding
activity of T cells to CD44 was up-regulated following their activa-
tion.4 However, the roles of this molecule in Th2- and Th17-
meidated allergic pathology have not been comparatively investi-
gated in vivo.
Therefore, in order to elucidate the contribution of CD44
expressed on Th2 and Th17 cells to the development of airway
inﬂammation, ovalbumin (OVA)-speciﬁc Th2 and Th17 cells were
differentiated from CD4þ T cells of DO11.10/RAG-2/ mice
in vitro, and then expression levels of CD44 were evaluated by
ﬂow cytometry. CD44 equivalently expressed on both cells,
whereas the binding ability of Th17 cells to hyaluronic acid (HA),
a ligand for CD44, was weaker than that of Th2 cells (Fig. 1A). We
have previously shown that HA-binding activity of CD44 is regu-
lated not only by its expression but also by a glycoside hydrolase
enzyme, neuraminidase.5 Therefore, the expression of neuramini-
dase subtypes in Th2 and Th17 cells was investigated by quantita-
tive real-time PCR (RT-PCR) (Fig. 1B). Neuraminidase 1 (Neu1)
mRNA level was signiﬁcantly higher in Th2 cells than Th17 cells,
whereas neuraminidase 3 (Neu3) similarly expressed in these cells.
The expression of neuraminidase 2 and 4 was not detectable (data
not shown). These ﬁndings suggest that the differential HA-binding
activity between Th2 and Th17 cells, despite of the equivalent CD44
expression, might be caused by Neu1 differentially expressed in
those cells.Peer review under responsibility of Japanese Society of Allergology.
http://dx.doi.org/10.1016/j.alit.2016.04.010
1323-8930/Copyright © 2016, Japanese Society of Allergology. Production and hosting by Else
licenses/by-nc-nd/4.0/).Next, the effect of anti-CD44 monoclonal Ab (mAb) on antigen-
induced lung inﬂammation was investigated in OVA-speciﬁc Th2
and Th17 cell-transferred mice. The antigen-speciﬁc T cells as
well as eosinophils were signiﬁcantly accumulated in the lungs of
Th2 cell-transferred mice upon antigen-challenge, whereas
massive neutrophil accumulation was induced by Th17 cells
(Fig. 2). Themigration of transferred Th17 cells was hardly observed
even after antigen challenge.
Treatment with anti-CD44 mAb signiﬁcantly suppressed the
inﬁltration of antigen-speciﬁc Th2 cells in the lungs. The accumula-
tions of eosinophils and neutrophils in Th2- and Th17-transferred
mice were not signiﬁcantly affected by the blockade of CD44
(Fig. 2). These ﬁndings suggest that CD44 plays a functional role
particularly in the migration of Th2 cells.
We also investigated the effects of anti-CD44 mAb on antigen-
induced BHR (Fig. 2). In agreement with our previous study,6 Th2
cell-transferred mice developed BHR upon antigen-challenge. It is
little surprising that Th17 cells also could induce BHR as well as
neutrophil inﬁltration without the migration of Th17 cells them-
selves. However, our present results are supported by the report
of McKinley et al. showing the development of steroid-resistant
airway inﬂammation accompanied by signiﬁcant BHR in Th17-
transferred mice.7 Therefore, antigen-speciﬁc Th17 cells coinciden-
tally located in the lungs just before antigen challengemight be suf-
ﬁcient for those inﬂammatory responses. Parallel with the results in
the migration of transferred T cells, anti-CD44 mAb suppressed Th2
but not Th17 cell-mediated BHR (Fig. 2). These results are consis-
tent with previous studies showing the direct contribution of T cells
to induce BHR.6e8 Since eosinophils have been implicated in the
development of BHR,9,10 accumulated eosinophils slightly but not
signiﬁcantly decreased by anti-CD44 treatment might also play
some roles in Th2-mediated BHR. Further investigations into rela-
tive contribution of Th2 cells and eosinophils in the pathogenesis
of allergic airway inﬂammation including the development of
BHR are required.
Conclusively, CD44 plays an important role in the development
of BHR mediated by Th2 cells but not Th17 cells. CD44 is a prom-
ising target for the treatment of allergic diseases dominantly medi-
ated by Th2 cells.vier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
Fig. 1. CD44 expression, HA-binding activity and neuraminidase expression in Th2 and Th17 cells. In vitro-polarized OVA-speciﬁc Th2 and Th17 cells were stained with anti-CD44
mAb or ﬂuorescein-conjugated (FL)-HA and analyzed by ﬂow cytometry. Isotype-matched control Abs were also used for and CD44 staining. The results shown are representatives
of two separate experiments (A). Messenger RNA expression of Neu1 and Neu3 in Th2 and Th17 cells was detected by RT-PCR. Data are expressed as mean ± SEM of two separate
experiments (n ¼ 4) normalized with glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression (B). *p < 0.05 compared with Th2 cells (Dunnett's method).
Fig. 2. Effects of anti-CD44 mAbs on antigen-induced airway inﬂammation in Th2- and Th17-transferred mice. Th2 and Th17 cells were stained with 5-(and -6)-carboxyﬂuorescein
diacetate succinimidyl ester (CFSE) and transferred to normal recipient mice as described in Supplementary Methods. Forty-eight hours after the antigen-challenge, BHR was eval-
uated as an increase in enhanced pause (Penh) following the provocation with 12.5 mg/ml methacholine. The numbers of eosinophils, neutrophils and CFSE-positive T cells in bron-
choalveolar lavage ﬂuid (BALF) were determined. Data are expressed as mean ± SEM of 4e10 animals. *p < 0.05, **p < 0.01 compared with OVA-challenged control mice (Dunnett's
method).
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